Blog

Tech Nation Visa: the gateway to world-leading UK tech jobs

At BenevolentAI we are always on the lookout for exceptional people to join us on our mission to re-engineer drug discovery and deliver life changing medicines to patients.


Our teams are curious, open to new ideas and passionate about making a positive impact on the world. At BenevolentAI we value different experiences, skills, and backgrounds and believe a diverse and inclusive environment is necessary to push technological and scientific boundaries. 

A globally diverse perspective is important, which is why we encourage the best tech talent from around the world to join us. As such, we want to draw attention to the Tech Nation Visa, also known as the Global Talent Visa in digital technology, which is a great initiative that enables the brightest international talent to live and work in the UK. 

Tech Nation, a close partner of BenevolentAI, has been designated by the Home Office to endorse applications for this Visa.  The application process is based on your unique background, skills, and achievements and there are two pathways to apply, depending on your experience:  Exceptional Talent and Exceptional Promise. The Tech Nation visa is highly flexible, not tied to a specific job, company or location. Applicants can have experience in any tech subsector and either business or technical backgrounds. It is granted for up to 5 years, with the ability to extend as many times as required. The Tech Nation Visa can also lead to permanent residency here in the UK.

Whether you have an established career in tech, or are finding your feet, the UK’s flourishing tech scene provides rich opportunities for entrepreneurs to set up or scale a business, or find employment at an existing firm. 52% of those endorsed last year by Tech Nation are now employed at leading UK tech firms, helping to fill existing talent gaps, while 28% have launched their own businesses. 

At BenevolentAI you have the chance to work alongside our world-leading experts, building tech which has real impact and contributes directly to our mission to improve patients’ lives. If you are a talented and creative individual interested in joining us on this mission, this could be your answer. 

Start building your career today, and find out more on the Tech Nation Visa guide here. 

Best of luck in your application.

The BenevolentAI Team


More Posts

You Might Also Like

News
BenevolentAI announces participation in upcoming investor conferences
BenevolentAI announces its participation at two upcoming biotech and healthcare investor conferences hosted by Goldman Sachs and Morgan Stanley.
Jun 10, 2022
News
BenevolentAI Announces Board Changes
BenevolentAI today announces the appointment of Dr. Susan Liautaud as a member of the board of directors of the Company with effect from 30 June 2022. Dr. Susan Liautaud will act as Independent Non-Executive Director of the Company.
May 25, 2022
News
BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
AstraZeneca selects another novel target for idiopathic pulmonary fibrosis from the collaboration for its drug development portfolio.
May 17, 2022
Blog
FDA converts emergency approval of baricitinib — first identified as a COVID treatment by BenevolentAI — to a full approval
The FDA has converted its emergency approval of baricitinib to a full approval, underscoring the strength of BenevolentAI’s AI-derived hypothesis.
May 12, 2022
News
BenevolentAI Begins Trading On Euronext Amsterdam
BenevolentAI, a leading, clinical-stage AI-enabled drug discovery company, announces that trading in its shares is expected to begin today, following completion of its business combination with Odyssey Acquisition S.A. on 22 April 2022.
Apr 25, 2022
Video
BenevolentAI · AI-Enabled Drug Discovery
Advanced technologies, combined with an exponential increase in biomedical data and research, provide an unparalleled opportunity to unravel the mysteries of diseases that have gone untreated for too long.
Apr 25, 2022